AtaiBeckley (ATAI) Minority Interest (2020 - 2026)

AtaiBeckley's (ATAI) quarterly Minority Interest came in at $96000.0 in Q1 2026, down 56.56% year-on-year from $221000.0 in Q1 2025, and down 24.41% quarter-over-quarter from $127000.0 in Q4 2025.

AtaiBeckley (ATAI) Minority Interest (2020 - 2026) Analysis & Trends

AtaiBeckley's Minority Interest history runs 3 years deep, the most recent figure standing at $96000.0 for Q1 2026.

  • On a quarterly basis, Minority Interest fell 56.56% year-over-year to $96000.0 in Q1 2026; TTM through Mar 2026 was $96000.0, a 56.56% decrease from a year earlier, with the FY2025 full-year figure at $127000.0, down 50.58% from the prior year.
  • Minority Interest slipped to $96000.0 in Q1 2026 per ATAI's latest filing, from $127000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $10.0 million in Q2 2021 to a low of $157000.0 in Q3 2025.
  • A 5-year average of $4.2 million and a median of $3.1 million in 2023 frame the typical range for Minority Interest.
  • Across the five-year window, Minority Interest tumbled 50.58% in 2025 and sank 56.56% in 2026, its largest moves.
  • Year by year, Minority Interest stood at $257000.0 in 2024, then tumbled by 50.58% to $127000.0 in 2025, then declined by 24.41% to $96000.0 in 2026.
  • Per Business Quant, the three latest ATAI Minority Interest figures stand at $96000.0 (Q1 2026), $127000.0 (Q4 2025), and $221000.0 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 AtaiBeckley 2.56 Bn 2.56 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 96,000.00
Dec 31, 2025 127,000.00
Sep 30, 2025 157,000.00
Jun 30, 2025 187,000.00
Mar 31, 2025 221,000.00
Mar 31, 2025 221,000.00
Dec 31, 2024 257,000.00
Dec 31, 2024 257,000.00
Sep 30, 2024 596,000.00
Jun 30, 2024 643,000.00
Mar 31, 2024 713,000.00
Dec 31, 2023 1.35 Mn
Sep 30, 2023 2.24 Mn
Jun 30, 2023 3.09 Mn
Mar 31, 2023 3.82 Mn
Dec 31, 2022 5.03 Mn
Sep 30, 2022 6.68 Mn
Jun 30, 2022 8.45 Mn
Mar 31, 2022 8.35 Mn
Dec 31, 2021 9.05 Mn